Background/Objectives: A case-control study was conducted to determine the association of the −238 G>A and −308 G>A TNF-alpha (TNFA) promoter polymorphisms with mRNA and protein expression in 180 Systemic Lupus Erythematosus (SLE) patients and 186 control subjects (CS) from western Mexico. Methods: Genotyping was performed using the PCR-RFLP method. TNFA mRNA expression was assessed by real-time quantitative PCR, and soluble TNF-α (sTNF-α) levels were quantified by ELISA. For comparison groups, Chi-square, Mann–Whitney U, or Kruskal–Wallis tests were used. Spearman’s rank correlation coefficient determined the correlation between variables. The Area Under the Curve was used to determine the diagnosing performance of sTNF-α. Results: No differences were found in the genotype distribution of −238 G>A and −308 G>A TNFA polymorphisms between SLE patients and CS. However, the −238A allele was associated with increased SLE susceptibility (OR 1.18 CI 95% 1.02–3.50, p = 0.037). Also, logistic regression analysis showed that LN risk was significantly higher in carriers of the −308A allele (OR 3.11 IC95% 1.15–6.43; p = 0.002). On the other hand, the TNFA mRNA expression was 3.3-fold higher in SLE compared to CS. SLE patients with −308 GG genotype showed higher TNFA mRNA expression compared to GA+AA genotype carriers (p < 0.01). Regarding sTNFa levels, SLE patients showed higher concentration than CS, mainly in lupus nephritis (LN), with a weak negative correlation with estimated Glomerular Filtration Rate and an acceptable accuracy for diagnosing SLE and LN, with areas under the curve of 0.61 and 0.65, respectively. Conclusions: The −238 A allele and −308 A allele of the TNFA gene are linked to a higher risk of susceptibility to SLE and LN in the western Mexican population. Additionally, SLE patients exhibited increased TNF-alpha gene expression and sTNF-α, particularly in LN, demonstrating acceptable diagnostic performance.
Background/Objectives: The increased frequency of circulating T follicular helper (cTfh) and T peripheral helper (Tph) cells in patients with systemic lupus erythematosus (SLE) and their association with higher disease activity have been reported. However, their role in the immunopathogenesis of SLE remains unclear. CCR2 and CCR5 have been identified on the surface of cTfh and Tph cells in autoimmune diseases such as Sjögren’s Disease. Methods: This study evaluates the association between CCR2+CCR5+cTfh and CCR2+CCR5+Tph cell frequencies and serum cytokine levels in patients with SLE and lupus nephritis (LN). Results: SLE patients showed higher frequencies of cTfh and Tph cells. Overall, CCR2 and CCR5 expression was higher in Tph cells than in cTfh cells. The frequency of CCR5+Tph and CCR5+cTfh cells was higher in patients with proliferative LN than in those with mixed-type LN. IL-21 correlated with the frequency of CCR2+CCR5+ Tph cells. In renal tissue, expression of CD4, CXCR5, CCR5, and CCR2 was more prominent in tubulo-interstitial areas with predominantly chronic lesions. Conclusions: Our results provide information on the expression of CCR2 and CCR5 in cTfh and Tph cells in SLE and offer insights into the association with inducing cytokines, highlighting the potential role of these cells in LN.